Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
- Resource Type
- Article
- Source
- In
American Journal of Kidney Diseases March 2024 83(3):293-305 - Subject
- Language
- ISSN
- 0272-6386